Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 2/20 | 0.70 |
| ▸ | THRB | P10828 | 1/20 | 0.70 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.70 |
| ▸ | CA2 | P00918 | 7/20 | 0.62 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.56 |
| ▸ | FYN | P06241 | 1/20 | 0.56 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.56 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.56 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.56 |
| ▸ | DRD4 | P21917 | 1/20 | 0.56 |
| ▸ | DRD3 | P35462 | 1/20 | 0.56 |
| ▸ | CA12 | O43570 | 6/20 | 0.55 |
| ▸ | CA1 | P00915 | 5/20 | 0.55 |
| ▸ | CA9 | Q16790 | 4/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | CA4 | P22748 | 2/20 | 0.51 |
| ▸ | CA5A | P35218 | 2/20 | 0.51 |
| ▸ | CA7 | P43166 | 2/20 | 0.51 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17327517 | 1.00 | CYP2D6 (0.70) | CYP2D6THRBHSD17B10CA2TSHR | |
| SCHEMBL19735717 | 1.00 | CYP2D6 (0.70) | CYP2D6THRBHSD17B10CA2TSHR | |
| SCHEMBL5410915 | 1.00 | CYP2D6 (0.70) | CYP2D6THRBHSD17B10CA2TSHR | |
| SCHEMBL24584612 | 1.00 | CYP2D6 (0.70) | CYP2D6THRBHSD17B10CA2TSHR | |
| SCHEMBL20524278 | 1.00 | CYP2D6 (0.70) | CYP2D6THRBHSD17B10CA2TSHR | |
| SCHEMBL23330709 | 1.00 | CYP2D6 (0.70) | CYP2D6THRBHSD17B10CA2TSHR | |
| SCHEMBL258821 | 1.00 | CYP2D6 (0.70) | CYP2D6THRBHSD17B10CA2TSHR | |
| SCHEMBL2723648 | 1.00 | CYP2D6 (0.70) | CYP2D6THRBHSD17B10CA2TSHR | |
| SCHEMBL502378 | 1.00 | CYP2D6 (0.70) | CYP2D6THRBHSD17B10CA2TSHR | |
| SCHEMBL13396023 | 1.00 | CYP2D6 (0.70) | CYP2D6THRBHSD17B10CA2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 876 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2831253-B1 | ENZYMES USEFUL FOR PERACID PRODUCTION | DUPONT US HOLDING LLC (US) | 2021-11-24 | — | — | EP | claimed |
| US-8962294-B2 | Perhydrolase variant providing improved specific activity | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2015-02-24 | — | — | US | claimed |
| US-8956843-B2 | Perhydrolase variant providing improved specific activity | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2015-02-17 | — | — | US | claimed |
| EP-2831253-A1 | ENZYMES USEFUL FOR PERACID PRODUCTION | E. I. Du Pont de Nemours and Company (US) | 2015-02-04 | — | — | EP | claimed |
| EP-2831226-A1 | ENZYMES USEFUL FOR PERACID PRODUCTION | E. I. Du Pont de Nemours and Company (US) | 2015-02-04 | — | — | EP | claimed |
| EP-2831252-A1 | ENZYMES USEFUL FOR PERACID PRODUCTION | E. I. Du Pont de Nemours and Company (US) | 2015-02-04 | — | — | EP | claimed |
| EP-2831250-A1 | ENZYMES USEFUL FOR PERACID PRODUCTION | E. I. Du Pont de Nemours and Company (US) | 2015-02-04 | — | — | EP | claimed |
| EP-2831251-A1 | ENZYMES USEFUL FOR PERACID PRODUCTION | E. I. Du Pont de Nemours and Company (US) | 2015-02-04 | — | — | EP | claimed |
| US-8911977-B2 | Enzymes useful for peracid production | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2014-12-16 | — | — | US | claimed |
| US-8865436-B2 | Enzymes useful for peracid production | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2014-10-21 | — | — | US | claimed |
| US-20080176783-A1 | Production of Peracids Using An Enzyme Having Perhydrolysis Activity | DUPONT US HOLDING, LLC | 2008-07-24 | — | — | US | claimed |
| US-20080176299-A1 | PRODUCTION OF PERACIDS USING AN ENZYME HAVING PERHYDROLYSIS ACTIVITY | DUPONT US HOLDING, LLC | 2008-07-24 | — | — | US | claimed |
| WO-2008073139-A1 | PRODUCTION OF PERACIDS USING AN ENZYME HAVING PERHYDROLYSIS ACTIVITY | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-06-19 | — | — | WO | claimed |
| US-6800742-B2 | Method for producing β-D-ribofuranose derivatives or optical isomers thereof | AJINOMOTO CO., INC. (JP) | 2004-10-05 | — | — | US | claimed |
| US-20020187942-A1 | Method for producing beta-D-ribofuranose derivatives or optical isomers thereof | AJINOMOTO CO., INC. (JP) | 2002-12-12 | — | — | US | claimed |
| EP-1260516-A1 | Method for producing a beta-D-ribofuranose derivative or an optical isomer thereof | Ajinomoto Co., Inc. (JP) | 2002-11-27 | — | — | EP | claimed |
| EP-0193903-B1 | PRODUCTION OF CYTOSINE NUCLEOSIDES | Takeda Chemical Industries, Ltd. (JP) | 1990-06-13 | — | — | EP | claimed |
| US-4801698-A | Process for preparing diaminopyrimido(4,5-d)pyrimidine glycoside and glycotide | WARNER-LAMBERT COMPANY (US) | 1989-01-31 | — | — | US | claimed |
| US-4689404-A | Production of cytosine nucleosides | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1987-08-25 | — | — | US | claimed |
| EP-0193903-A2 | Production of cytosine nucleosides | Takeda Chemical Industries, Ltd. (JP) | 1986-09-10 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020187942-A1 | Method for producing beta-D-ribofuranose derivatives or optical isomers thereof | DERA, RNGTT, DUT | CYP2D6 302/4885THRB 1004/4885HSD17B10 1438/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.